H

HLB Life Science Co Ltd
KOSDAQ:067630

Watchlist Manager
HLB Life Science Co Ltd
KOSDAQ:067630
Watchlist
Price: 4 580 KRW 6.51% Market Closed
Market Cap: ₩558.4B

Operating Margin

-28.5%
Current
Declining
by 2.6%
vs 3-y average of -25.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-28.5%
=
Operating Income
₩-23.3B
/
Revenue
₩81.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-28.5%
=
Operating Income
₩-23.3B
/
Revenue
₩81.5B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
HLB Life Science Co Ltd
KOSDAQ:067630
523.9B KRW
Loading...
US
Mckesson Corp
NYSE:MCK
100.9B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
68.4B USD
Loading...
US
Cencora Inc
NYSE:COR
67.8B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
49.6B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.2B AUD
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
66.1B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.2B USD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.8B CNY
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
64.9B HKD
Loading...

Market Distribution

Lower than 89% of companies in Korea
Percentile
11th
Based on 2 615 companies
11th percentile
-28.5%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

HLB Life Science Co Ltd
Glance View

Market Cap
558.4B KRW
Industry
Health Care

HLB Life Sciences Co., Ltd. engages in the provision of energy saving services. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2008-11-25. Along with subsidiaries, the Company operates its business through four segments. The Pharmaceutical Distribution segment is involved in the sale of pharmaceuticals and raw materials through SHINWHAADVANCE.CO.LTD. The Energy Business segment is engaged in energy service company (ESCO) business. The company is equipped with equipments, assets and technical personnel to engage in energy saving investment business. The Bio Development segment is engaged in the development of extracorporeal circulation type bio space, hepatocyte treatment agents and hemostatic agents. The main products include anticancer drugs such as Tegatrabetan and Seclidemstat. The Other Business segment is involved in the investment of small business start-ups and venture businesses, as well as manufacturing and sale of light emitting diode (LED) products.

HLB Life Science Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-28.5%
=
Operating Income
₩-23.3B
/
Revenue
₩81.5B
What is HLB Life Science Co Ltd's current Operating Margin?

The current Operating Margin for HLB Life Science Co Ltd is -28.5%, which is below its 3-year median of -25.9%.

How has Operating Margin changed over time?

Over the last 3 years, HLB Life Science Co Ltd’s Operating Margin has decreased from -24.6% to -28.5%. During this period, it reached a low of -36.6% on Sep 30, 2023 and a high of -19.1% on Mar 31, 2023.

Back to Top